Tailoring the release rates of fluconazole using solid dispersions in polymer blends

Drug Development and Industrial Pharmacy

Volumn 34, Issue 3, 2008, Pages 336-346

  Papageorgiou, George Z ^a   Bikiaris, Dimitrios ^a   Kanaze, Feras I ^b   Karavas, Evangelos ^b   Stergiou, Anagnostis ^a   Georgarakis, Emmanouil ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Pharmaceutical Industry   (Greece)

Author keywords

Chitosan; Dissolution rates; Fluconazole; HPMC; Miscible blends; PVP; Solid dispersion

Indexed keywords

CHITOSAN; FLUCONAZOLE; HYDROXYPROPYLMETHYLCELLULOSE; POVIDONE;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED DRUG RELEASE; DISPERSION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; MISCIBILITY; PARTICLE SIZE; SOLID; WETTABILITY;

ANTIFUNGAL AGENTS; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FLUCONAZOLE; METHYLCELLULOSE; PARTICLE SIZE; POLYMERS; POVIDONE; SOLUBILITY; WETTABILITY;

EID: 41149091694     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701662669     Document Type: Article

References (39)

1. Ayub, A. C., Gomes, A. D. M., Lima, M. V. C., Vianna-Soares, C. D., & Ferreira, L. A. M. (2007). Topical delivery of Fluconazole: In vitro skin penetration and permeation using emulsions as dosage forms. Drug D. Ind. Pharm., 33(3), 233-245.
2. Bikiaris, D., Papageorgiou, G. Z., Stergiou, A., Pavlidou, E., Karavas, E., Kanaze, F., & Georgarakis, M. (2005). Physicochemical studies on solid dispersions of poorly-water soluble drugs. Evaluation of capabilities and limitations of thermal analysis. Thermochemica Acta, 439, 58-67.
3. Bikiaris, D., Prinos, J., Botev, M., Betchev, C., & Panayiotou, C. (2004). Miscibility behaviour of polymer blends prepared from components with similar glass transitions using dynamic mechanical thermal analysis and differential scanning calorimetry. J. Appl. Polym. Sci., 93, 726-735.
4. Craig, D. Q. M. (1995). A review of thermal methods used for the analysis of the crystal form, solution thermodynamics and glass transition behaviour of polyethylene glycols. Thermochi. Acta, 248, 189-203.
5. Craig, D. Q. M. (2002). The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm., 231, 131-144.
6. Edlund, U., & Albertsson, A.-C. (2000). Microspheres from poly(D,L-lactide)/poly(1,5-dioxepan-2-one) miscible blends for controlled drug delivery. J. Bio. Comp. Polym., 15, 214-221.
7. Fekete, P., Virgula, J., Furdyga, E., Leventiszne, H. M., Klebovich, I., & Baloghne, N. K. (2005). Fluconazole capsules with improved release. WO Patent, 2005002553.
8. Ford, J. L. (1986). The current status of solid dispersions. Pharm. Acta Helv., 61, 69-88.
9. Gu, X. J., & Jiang, W. (1995) Characterization of polymorphic forms of Fluconazole using transform raman spectroscopy. J. Pharm. Sci., 84(12), 1438-1441.
10. Gupta, P., & Bansal, A. K. (2005). Devitrification of amorphous celecoxib. AAPS Pharm. Sci. Tech., 6, E223-E230.
11. Gupta, P., Thilagavathi, R., Chakraborti, A. K., & Bansal, A. K. (2005). Role of molecular interactions in stability of celecoxib-PVP amorphous systems. Mol. Pharm., 2, 384-391.
12. Hörter, D., & Dressman, J. B. (2001). Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev., 56, 75-87.
13. Hu, J., Johnston, K. P., & Williams, R. O. III. (2004). Nanoparticle engineering processes for enhancing the dissolution rates of poorly watersSoluble drugs. Drug Dev. Ind. Pharm., 30(3), 233-245.
14. Kanaze, F. I., Kokkalu, E., Niopas, I., Georgarakis, E., Stergiou, A., & Bikiaris, D. (2006). Dissolution enhancement of flavonoids by solid dispersion in PVP and PEG matrices. A comparative study. J. Appl. Polym. Sci., 102, 460-471.
15. Karavas, E., Ktistis, G., Xenakis, A., & Georgarakis, E. (2006a). Effect of hydrogen bonding interactions on the release mechanism of Felodipine from nanodispersions with poly(vinyl pyrrolidone). Eur J Pharm Biopharm., 63, 103-114.
16. Karavas, E., Georgarakis, E., & Bikiaris, D. (2006b). Adjusting drug release by using miscible polymer blends as effective drug carriers. J. Therm. Anal. Cal., 84, 125-133.
17. Karavas, E., Georgarakis, E., & Bikiaris, D. (2006c). Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur. J. Pharm. Bio., 64, 115-126.
18. Karavas, E., Georgarakis, E., & Bikiaris, D. (2006d). Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. Int. J. Pharm., 313, 189-197.
19. Karavas, E., Georgarakis, E., Bikiaris, D., Thomas, T., Katsos, V., & Xenakis, A. (2001). Hydrophilic matrices as carries in felodipine solid dispersion systems. Progr. Coll. Polym. Sci., 118, 149-152.
20. Karavas, E., Georgarakis, E., Sigalas, M. P., Avgoustakis, K., & Bikiaris, D. (2007). In situ investigation of the release mechanism of a sparingly water-soluble drug from its solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions. Eur. J. Pharm. Bio. 340, 76-83.
21. Kaushal, A. M., Gupta, P., & Bansal, A. K. (2004). Amorphous drug delivery systems: Molecular aspects, design and performance. Crit. Rev. Ther. Drug Carrier Syst., 21, 133-193.
22. Koo, C. G. L., Frantzich, S., Rosinski, A., Sjöström, M., & Hoogstraate, J. (2003). Oral gingival delivery systems from chitosan blends with hydrophilic polymers. Eur. J. Pharm. Biopharm., 55, 47-56.
23. Leuner, C., & Dressman, J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm., 50, 47-60.
24. Lyu, S. P., Sparer, R., Hobot, S., & Dang, K. (2005). Adjusting drug diffusivity using miscible polymer blends. J. Controlled Release, 102, 679-686.
25. Matsumoto, T., & Zografi, G. (1999). Physical properties of solid molecular dispersion of Indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to Indomethacin Crystallization. Pharm. Res, 16, 1722-1728.
26. Mitchell, S. A., Reynolds, T. D., & Dasbach, T. P. (2003). A compaction process to enhance dissolution of poorly water-soluble drugs using hydroxypropyl methylcellulose Int. J. Pharm., 250, 3-11.
27. Nyamweya, N., & Hoag, S. W. (2000). Assessment of polymer-polymer interactions in blends of HPMC and film forming polymers by modulated temperature differential scanning calorimetry. Pharm. Res., 17, 625-631.
28. Okimoto, K., Miyake, M., Ibuki, R., Yasumura, M., Ohnishi, N., & Nakai, T. (1997). Dissolution mechanism and rate of solid disperion particles of nivaldipine with hydroxypropylmethylecellulose. Int. J. Pharm., 159, 85-93.
29. Pandit, N. K., Strykowski, J. M., McNally, E. J., & Waldbillig, A. M. (1985). Surfactant solutions as media for dissolution testing of a poorly water-soluble drug. Drud. Dev. Ind. Pharm., 32(5), 559-567.
30. Papageorgiou, G. Z., & Bikiaris, D. N. (2006). Miscibility study of poly(propylene succinate)/poly(ethylene succinate) and poly(ethylene succinate)/poly(butylene succinate) blends. J. Polym. Sci. Polym. Phys. 44, 584-597.
31. Papageorgiou, G. Z., Bikiaris, D., Karavas, E., Politis, S., Docoslis, A., Park Y., Stergiou, A., & Georgarakis, E. (2006). Effect of physical state and particle size distribution on dissolution enhancement of Nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation. The APPS Journal, 8, E623-E631.
32. Porta, V., Chang, K. H., & Storpirtis, S. (2005). Evaluation of the bioequivalence of capsules containing 150 mg of fluconazole. Int. J. Pharm., 288, 81-86.
33. Serajudin, A. T. M. (1999). Solid dispersion of poorly water soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci., 88, 1058-1066.
34. Tantishaiyakul, V., Kaewnopparat, N., & Ingkatawornwong. S (1999). Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int. J. Pharm., 181,143-151.
35. Tomkins, A., Kontopoulou, M., & Amsden, B. (2005). Preparation and characterization of blends of star-poly(ε-caprolactone-co-D,L-lactide) and oligo (ε-caprolactone). J. Biomater. Sci., Polym. Ed., 16, 1009-1017.
36. Van den Mooter, G., Wuyts, M., Blaton, N., Busson, R., Grobet, P., Augustijns, P., & Kinget, R. (2001). Physical stabilization of amorphous ketoconazole in solid dispersion with polyvinylpyrrolidone K25. Eur. J. Pharm. Sci., 12, 261-269.
37. Vaughn, J., McConville, J. T., Crisp, M. T., Johnston, K. P., & Williams R. O. 3rd. (2006). Supersaturation produces high bioavailability of amorphous danazol particles formed by evaporative precipitation into aqueous solution and spray freezing into liquid technologies. Drug Dev. Ind. Phram., 32(5), 559-567.
38. Verheyen, S., Blaton, N., Kinget, R., & Van den Mooter, G. (2002). Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J. Pharm., 249, 45-58.
39. Wong, S. M., Kellaway, I. W., & Murdan, S. (2006) Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant containing microparticles. Int. J. Pharm. 317(1), 61-68.